Cidara Therapeutics, Inc. (CDTX) Stock Price, Quote & AI Analysis
Live CDTX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Cidara Therapeutics, Inc..
TradeVae provides AI-driven analysis and real-time market intelligence for Cidara Therapeutics, Inc. (NASDAQ: CDTX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Cidara Therapeutics, Inc.'s fundamentals reflect its scale, profitability, and position within the global BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Cidara Therapeutics, Inc. Overview
Company information
Company Overview
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Cidara Therapeutics, Inc. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...